Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

It’s a new way to create “bi-paternal” mice that can survive to adulthood—but human applications are still a long way off.

Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...

In 2019, the first CRISPR clinical trials were conducted to treat sickle cell diseases and in 2020, this treatment was ...

The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more ...

Researchers use CRISPR to overcome seemingly insurmontable reproductive barriers — but that doesn't mean this could work for ...

A GROUNDBREAKING genetic treatment with the potential to cure sickle cell disease will be rolled out on the NHS. The one-off ...

Charity organisation Sickle Cell Society has described the recommendation as a “major breakthrough” for sickle cell patients.

With a rise in Trikafta demand, the investors have assigned a higher valuation multiple for VRTX stock. The increase in VRTX ...

People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...

NHS officials estimate that around 50 people a year will receive treatment now that it has been approved for use for certain ...